Literature DB >> 32550984

Ligand Design for Cereblon Based Immunomodulatory Therapy.

Robert B Kargbo1.   

Abstract

Year:  2020        PMID： 32550984      PMCID： PMC7294553          DOI： 10.1021/acsmedchemlett.0c00214

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

1.  PROTAC Technology: Opportunities and Challenges.

Authors:  Hongying Gao; Xiuyun Sun; Yu Rao
Journal:  ACS Med Chem Lett       Date:  2020-03-12       Impact factor: 4.345

Review 2.  Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery.

Authors:  George M Burslem; Craig M Crews
Journal:  Cell       Date:  2020-01-16       Impact factor: 41.582

3.  Degrading proteins in animals: "PROTAC"tion goes in vivo.

Authors:  Jianping Guo; Jing Liu; Wenyi Wei
Journal:  Cell Res       Date:  2019-03       Impact factor: 25.617

Review 4.  Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance.

Authors:  Lisa C Holthof; Tuna Mutis
Journal:  Cancers (Basel)       Date:  2020-04-17       Impact factor: 6.639

Review 5.  Novel immunomodulatory drugs and neo-substrates.

Authors:  Shaobing Gao; Shichao Wang; Yongping Song
Journal:  Biomark Res       Date:  2020-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.